Short Peptides Protect Oral Stem Cells from Ageing
Bruna Sinjari1, Francesca Diomede1, Vladimir Khavinson2,3,4
1Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.
Stem Cell Reviews and Reports
|November 3, 2019
Summary
Short peptides AEDG and KED delay senescence in human mesenchymal stem cells (hMSCs). These findings support using peptides to maintain hMSC morphology and function for clinical applications requiring large cell numbers.
Area of Science:
- Stem Cell Biology
- Gerontology
- Biotechnology
Background:
- Primary stem cells, including human mesenchymal stem cells (hMSCs), enter senescence after prolonged division, altering morphology and limiting clinical use.
- Senescence in hMSCs poses a significant challenge for cell therapies requiring large cell quantities.
- Short peptides have demonstrated geroprotective effects and the ability to stimulate stem cell differentiation.
Purpose of the Study:
- To investigate the role of AEDG and KED peptides in preserving the morphology and function of oral hMSCs during long-term expansion.
- To evaluate the potential of these peptides to mitigate senescence in cultured hMSCs.
Main Methods:
- Two types of oral hMSCs, human periodontal ligament stem cells (hPLSCs) and human gingival mesenchymal stem cells (hGMSCs), were cultured.
- Cells at passage 25 were divided into control, AEDG peptide-treated, and KED peptide-treated groups.
- Senescence markers (p16 and p21) expression was analyzed using RT-PCR and immunofluorescence.
Main Results:
- AEDG peptide treatment reduced p16 and p21 mRNA expression by 1.56-2.44 times compared to controls.
- KED peptide treatment reduced p16 and p21 mRNA expression by 1.82-3.23 times compared to controls.
- Immunofluorescence confirmed the reduced expression of senescence markers in peptide-treated groups.
Conclusions:
- AEDG and KED peptides exhibit geroprotective effects, delaying senescence marker expression in long-term hMSC cultures.
- These peptides can be utilized as supplementary agents in culture media to support large-scale in vitro expansion of hMSCs.
- The findings support the clinical application of stem cell therapy by enabling the necessary expansion of functional cells.
Related Concept Videos
01:12Renewal of Skin Epidermal Stem Cells
2.9K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.9K
01:23Tissue Renewal without Stem Cells
2.1K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
2.1K
01:26Stem Cell Niche
6.1K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.1K
01:23Renewal of Intestinal Stem Cells
3.1K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.1K
01:19Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K
01:19Multipotency of Hematopoietic Stem Cells
3.7K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K